-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
OptimizeRx Corp quarterly/annual Cost of Revenue history and growth rate from 2018 to 2023.
- OptimizeRx Corp Cost of Revenue for the quarter ending March 31, 2024 was $7.49 M, a 34.4% increase year-over-year.
- OptimizeRx Corp Cost of Revenue for the twelve months ending March 31, 2024 was $30.5 M, a 30.4% increase year-over-year.
- OptimizeRx Corp annual Cost of Revenue for 2023 was $28.6 M, a 21.9% increase from 2022.
- OptimizeRx Corp annual Cost of Revenue for 2022 was $23.5 M, a 8.46% decline from 2021.
- OptimizeRx Corp annual Cost of Revenue for 2021 was $25.7 M, a 33.6% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)